Highlights that despite the generally low risk of stent thrombosis with everolimus-eluting stents, it can still occur due to factors like limited coronary flow and antiplatelet resistance.
Answers are grounded in this paper and cite their sources.
Alerts to multifactorial ST risks despite modern stents; leaves open whether flow or resistance testing improves prevention.
Stent thrombosis (ST) is a serious complication of percutaneous coronary intervention. Several factors are associated with ST, and combination of these factors increase the risk, even in everolimus-eluting stents, which have low risk of ST. We experienced a case of ST caused by limited coronary flow and resistance to antiplatelet agent.
No takes yet. Share an insight, caveat, or question.
Naito et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: